Thalidomide-O-PEG2-NHS ester

• Description:

  Thalidomide-O-PEG2-NHS ester, is synthesized compound that incorporatess the Thalidomide based cereblon ligand and the PEG linker used in PROTAC technology.

• UNSPSC:

  12352005

• Hazard Statement:

  H315, H319

• Target:

  E3 Ligase Ligand-Linker Conjugates

• Related Pathways:

  PROTAC

• Field of Research:

  Cancer

• Smiles:

  O=C(CCOCCOCCOC1=CC=CC(C(N2C3C(NC(CC3)=O)=O)=O)=C1C2=O)ON4C(CCC4=O)=O

• Molecular Formula:

  C24H25N3O11

• Molecular Weight:

  531.47

• Precautions:

  H315, H319

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  -20°C, 3 years; 4°C, 2 years (Powder)

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  [2639395-34-7]